Tessella Biosciences
PrivateLast Round
Grant
Mar 12, 2026
Total Funding Raised
$326,000
Company Overview
Tessella Biosciences Inc. is a biotechnology company that develops and commercializes bioinks for 3D bioprinting, tissue engineering, and regenerative medicine.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tessella Biosciences Comps
Public and private peers based on sector, stage, and business model.
Tessella Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 12, 2026 | ||||
| Seed | Oct 6, 2025 |
Tessella Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioCreate Program | Grant |
| McMaster Seed Fund | Seed |
| Federal Economic Development Agency for Southern Ontario | Grant |
| Ontario Genomics | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2026
$150K grant from BioCreate Program, Federal Economic Development Agency, and Ontario Genomics.
- Oct 6, 2025
$176K round led by McMaster Seed Fund
Tessella Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tessella Biosciences's valuation, stock price, and market status.
